The Journal of Medical Toxicology, the official journal of the American College of Medical Toxicology, publishes a study evaluating the effectiveness of an unproven topical treatment for autism in its March issue.
Phoenix, AZ (PRWEB) February 26, 2013
In the study, the researchers were unable to detect any DMPS in the blood following its application, demonstrating that the product is not absorbed through the skin. Without absorption, TD-DMPS cannot exert its purported effects of removing heavy metals from the body. The study confirmed this by demonstrating that the urinary elimination of mercury, a metal known to be removed from the body when DMPS is given by mouth or the intravenous route, did not increase after application of the product.
According to an accompanying editorial by Charles McKay MD, Medical Director of the Department of Occupational Health Services and Section Chief of the Division of Medical Toxicology at Hartford Hospital in Connecticut, Despite the absence of data, and in the face of such concerns about absorption and dose, many advocates of a heavy metal toxic etiology for autism (in particular mercury) have incorporated TD-DMPS into their non-traditional practice. We should recognize, however, the frustration and despair that leads members of the public to embrace homeopathy, detoxifying regimens, and the like.
ACMT is a professional, nonprofit association of physicians with recognized expertise in medical toxicology. The College is dedicated to advancing the science and practice of medical toxicology through a variety of activities.
ACMT American College of Medical Toxicology 623-533-6340 Email Information
More:
Medical Myth Busting - Journal of Medical Toxicology Debunks Treatment for Autism